Where Are They Now: Mike Sapieha — Bringing Innovation from the Bench to the Bedside for Aging Eye Diseases
Dr. Przemyslaw (Mike) Sapieha wants to move new discoveries from the lab bench to patients, where they can make a difference. And as the University of Montreal Endowed Chair in Translational Vision…
Dr. Mike Sapieha Wins Prestigious Cogan Award
Did you know that obesity is the second most important environmental risk factor for wet age-related macular degeneration (AMD)? At Fighting Blindness Canada (FBC), we are very proud to be funding Dr….
Funding Results
Fighting Blindness Canada (FBC) is the largest charitable funder of vision research in Canada. On this page, you will find information on grants FBC has awarded since 2015. Jump to: Research Grants…
Research News
July 2024 First patients treated in XLRP gene therapy trial Beacon Therapeutics, has announced that they have treated the first patients in their Phase 2/3 VISTA trial for a gene therapy for…
Your Gut’s Influence on the Development of Blinding Eye Diseases
FBC-funded scientist Dr. Mike Sapieha is an associate professor at the University of Montreal. This year, he was the recipient of ARVO’s prestigious Cogan Award, which recognizes an outstanding researcher under the…
From Bench to Bedside and Back Again: ARVO Comes to Canada
The phrase “from the bench to the bedside” is often used to describe the path to new medical treatments, beginning with a discovery at the laboratory “bench” and finishing when patients can…
Join the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.
